Skip to main content
. 2020 Aug 11;26:e924858-1–e924858-15. doi: 10.12659/MSM.924858

Table 1.

Description of the early death for patients with IV breast cancer in the construction cohort.

Subject characteristics Patients No. (%)
No early death Total early death Cancer specific early death Non-cancer specific early death
Age
 <50 2790 (22.5) 645 (10.8) 521 (11.8) 124 (7.8)
 50–59 3256 (26.2) 1178 (19.6) 923 (20.9) 255 (16.1)
 60–69 3267 (26.3) 1506 (25.1) 1128 (25.5) 378 (23.9)
 70–79 1952 (15.7) 1318 (22.0) 940 (21.3) 378 (23.9)
 ≥80 1143 (9.2) 1351 (22.5) 904 (20.5) 447 (28.3)
Marital status
 Married 5790 (46.7) 1993 (33.2) 1477 (33.4) 516 (32.6)
 Unmarried 5922 (47.7) 3674 (61.3) 2697 (61.1) 977 (61.8)
 Unknown 696 (5.6) 331 (5.5) 242 (5.5) 89 (5.6)
Race
 White 9466 (76.3) 4409 (73.5) 3252 (73.6) 1157 (73.1)
 Black 1906 (15.4) 1208 (20.1) 881 (20) 327 (20.7)
 Others 987 (8.0) 369 (6.2) 274 (6.2) 95 (6.0)
 Unknown 49 (0.4) 12 (0.2) 9 (0.2) 3 (0.2)
Insurance
 Insured 11727 (94.5) 5527 (92.1) 4033 (91.3) 1494 (94.4)
 Uninsured 437 (3.5) 308 (5.1) 265 (6.0) 43 (2.7)
 Unknown 244 (2.0) 163 (2.7) 118 (2.7) 45 (2.8)
Subtypes
 Luminal A 7274 (58.6) 2295 (38.3) 1645 (37.3) 650 (41.1)
 Luminal B 1961 (15.8) 544 (9.1) 427 (9.7) 117 (7.4)
 HER2 enriched 891 (7.2) 424 (7.1) 323 (7.3) 101 (6.4)
Triple negative 908 (7.3) 1164 (19.4) 871 (19.7) 293 (18.5)
 Unknown 1374 (11.1) 1571 (26.2) 1150 (26) 421 (26.6)
Grade
 Grade I 979 (7.9) 212 (3.5) 140 (3.2) 72 (4.6)
 Grade II 4401 (35.5) 1432 (23.9) 1021 (23.1) 411 (26)
 Grade III 4220 (34.0) 2220 (37.0) 1689 (38.2) 531 (33.6)
 Grade IV 56 (0.5) 45 (0.8) 37 (0.8) 8 (0.5)
 Unknown 2752 (22.2) 2089 (34.8) 1529 (34.6) 560 (35.4)
Tumor site
 UOQ 2930 (23.6) 1141 (19) 832 (18.8) 309 (19.5)
 LOQ 684 (5.5) 226 (3.8) 162 (3.7) 64 (4.0)
 LIQ 453 (3.7) 154 (2.6) 104 (2.4) 50 (3.2)
 UIQ 794 (6.4) 284 (4.7) 204 (4.6) 80 (5.1)
 CEN 761 (6.1) 288 (4.8) 212 (4.8) 76 (4.8)
 Others 2577 (20.8) 1059 (17.7) 767 (17.4) 292 (18.5)
 Unknown 4209 (33.9) 2846 (47.4) 2135 (48.3) 711 (44.9)
Laterality
 Left-sided 6030 (48.6) 2848 (47.5) 2110 (47.8) 738 (46.6)
 Right-sided 5799 (46.7) 2684 (44.7) 1972 (44.7) 712 (45.0)
 One side, NOS 51 (0.4) 35 (0.6) 29 (0.7) 6 (0.4)
 Paired sides 528 (4.3) 431 (7.2) 305 (6.9) 126 (8.0)
Tumor size
 0–2 cm 1937 (15.6) 705 (11.8) 438 (9.9) 267 (16.9)
 2–5 cm 4721 (38.0) 1871 (31.2) 1346 (30.5) 525 (33.2)
 >5 cm 3263 (26.3) 1580 (26.3) 1274 (28.8) 306 (19.3)
 Unknown 2487 (20.0) 1842 (30.7) 1358 (30.8) 484 (30.6)
N stage
 N0 2860 (23.0) 1490 (24.8) 991 (22.4) 499 (31.5)
 N1 4321 (34.8) 1634 (27.2) 1266 (28.7) 368 (23.3)
 N2 1131 (9.1) 370 (6.2) 276 (6.3) 94 (5.9)
 N3 3092 (24.9) 1613 (26.9) 1237 (28) 376 (23.8)
 Unknown 1004 (8.1) 891 (14.9) 646 (14.6) 245 (15.5)
Bone Met
 No 3562 (28.7) 2156 (35.9) 1525 (34.5) 631 (39.9)
 Yes 8846 (71.3) 3842 (64.1) 2891 (65.5) 951 (60.1)
Brain Met
 No 11786 (95.0) 5178 (86.3) 3792 (85.9) 1386 (87.6)
 Yes 622 (5.0) 820 (13.7) 624 (14.1) 196 (12.4)
Liver Met
 No 9722 (78.4) 3820 (63.7) 2712 (61.4) 1108 (70)
 Yes 2686 (21.6) 2178 (36.3) 1704 (38.6) 474 (30)
Lung Met
 No 8861 (71.4) 3527 (58.8) 2521 (57.1) 1006 (63.6)
 Yes 3547 (28.6) 2471 (41.2) 1895 (42.9) 576 (36.4)
Surgery
 No surgery 8177 (65.9) 5094 (84.9) 3785 (85.7) 1309 (82.7)
 PM 1174 (9.5) 298 (5.0) 195 (4.4) 103 (6.5)
 TM 984 (7.9) 201 (3.4) 132 (3) 69 (4.4)
 RM 1851 (14.9) 339 (5.7) 251 (5.7) 88 (5.6)
 Others 38 (0.3) 9 (0.2) 5 (0.1) 4 (0.3)
 Unknown 184 (1.5) 57 (1.0) 48 (1.1) 9 (0.6)

UOQ – upper outer quadrant; LOQ – lower outer quadrant; LIQ – lower inner quadrant; UIQ – upper inner quadrant; CEN – central portion; NOS – not otherwise specified; PM – partial mastectomy; TM – total mastectomy; RM – radical mastectomy.